Hanxuan (Astrid) Yu and Janice Jhang join the PhD Program in Health Policy, decision science track in Fall, 2024.
The U.S. government recently released a report on its research priorities, focusing on issues related to estimating policy impacts and valuing outcomes. Jeffrey Shrader discussed these priorities in a seminar co-sponsored by CHDS and the Harvard Chan School Department of Health Policy and Management and Department of Environmental Health.
Disability-adjusted life years and quality-adjusted life years are typically treated as alternative outcome measures. John A. Graves presented three approaches to incorporating these multidimensional health outcome measures in common decision analytic modeling frameworks in a CHDS seminar.
Accounting for both heterogeneity and biases in economic evaluations presents difficult challenges, which can be addressed by simulation models as discussed in Fernando Alarid-Escudero’s CHDS seminar.
CHDS’ Jagpreet Chhatwal moderated “Emerging Landscape of Health Economic Evaluation in the Era of Generative AI” at the 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting.
